Literature DB >> 19332633

A functional haplotype of PADI4 gene in rheumatoid arthritis: positive correlation in a French population.

Frédérique Gandjbakhch1, Isabelle Fajardy, Benjamin Ferré, Sylvain Dubucquoi, René-Marc Flipo, Nadine Roger, Elisabeth Solau-Gervais.   

Abstract

OBJECTIVE: A functional haplotype of peptidyl arginine deiminase 4 (PADI4) was associated with susceptibility to rheumatoid arthritis (RA) in Asian populations, but the results are contradictory in Europeans. We investigated (1) the association of 2 single-nucleotide polymorphisms (SNP) located in exon 2 of PADI4 with RA in another Caucasian population; and (2) the association between PADI4 and anti-citrullinated protein (anti-CCP) antibodies.
METHODS: DNA samples were obtained from 405 French RA patients and 275 controls. All RA patients met the revised criteria of the American College of Rheumatology. PADI4_89 163(G-->A) and PADI4_90 245(T-->C) SNP were genotyped using a PCR-RFLP method confirmed by direct sequencing. All patients and controls were genotyped for HLA-DRB1. The presence of anti-CCP antibodies was tested in 243 RA patients using an ELISA technique.
RESULTS: We focused on PADI4_89 163(G-->A) and PADI4_90 245(T-->C) SNP that distinguished 2 main haplotypes: AC haplotype (PADI4_89*A PADI4_90*C) and GT haplotype (PADI4_89*G PADI4_90*T), described, respectively, as "nonsusceptible" and "susceptible." A positive association between RA and presence of the GT haplotype was found in the heterozygous state (p = 0.002) and the homozygous state (RA patients 22%, controls 13%; p = 0.005). A correlation was observed between the presence but not the level of anti-CCP antibodies and the GT heterozygous (p = 0.03) and homozygous (p = 0.05) haplotypes. No correlation was found between the HLA-DRB1 shared epitope and any of the PADI4 haplotypes.
CONCLUSION: Our findings confirm those of Japanese, Korean, and Canadian studies and suggest that PADI4 may be a new susceptibility gene independent of HLA-DRB1 for RA in Caucasian populations.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19332633     DOI: 10.3899/jrheum.080398

Source DB:  PubMed          Journal:  J Rheumatol        ISSN: 0315-162X            Impact factor:   4.666


  11 in total

1.  Association study of single nucleotide polymorphisms in pre-miRNA and rheumatoid arthritis in a Han Chinese population.

Authors:  Bin Yang; Jun Long Zhang; Yun Ying Shi; Dong Dong Li; Jie Chen; Zhuo Chun Huang; Bei Cai; Xing Bo Song; Li Xin Li; Bin Wu Ying; Lan Lan Wang
Journal:  Mol Biol Rep       Date:  2010-12-22       Impact factor: 2.316

Review 2.  Ethnogenetic heterogeneity of rheumatoid arthritis-implications for pathogenesis.

Authors:  Yuta Kochi; Akari Suzuki; Ryo Yamada; Kazuhiko Yamamoto
Journal:  Nat Rev Rheumatol       Date:  2010-03-16       Impact factor: 20.543

Review 3.  Protein arginine deiminase 4 (PAD4): Current understanding and future therapeutic potential.

Authors:  Justin E Jones; Corey P Causey; Bryan Knuckley; Jessica L Slack-Noyes; Paul R Thompson
Journal:  Curr Opin Drug Discov Devel       Date:  2009-09

4.  Autodeimination of protein arginine deiminase 4 alters protein-protein interactions but not activity.

Authors:  Jessica L Slack; Larry E Jones; Monica M Bhatia; Paul R Thompson
Journal:  Biochemistry       Date:  2011-04-20       Impact factor: 3.162

Review 5.  Genetics of rheumatic disease.

Authors:  Alex Clarke; Timothy J Vyse
Journal:  Arthritis Res Ther       Date:  2009-10-14       Impact factor: 5.156

6.  Peptidyl arginine deiminase type IV (PADI4) haplotypes interact with shared epitope regardless of anti-cyclic citrullinated peptide antibody or erosive joint status in rheumatoid arthritis: a case control study.

Authors:  So-Young Bang; Tae-Un Han; Chan-Bum Choi; Yoon-Kyoung Sung; Sang-Cheol Bae; Changwon Kang
Journal:  Arthritis Res Ther       Date:  2010-06-10       Impact factor: 5.156

7.  Peptidylarginine deiminase 2 is required for tumor necrosis factor alpha-induced citrullination and arthritis, but not neutrophil extracellular trap formation.

Authors:  Mandar Bawadekar; Daeun Shim; Chad J Johnson; Thomas F Warner; Ryan Rebernick; Dres Damgaard; Claus H Nielsen; Ger J M Pruijn; Jeniel E Nett; Miriam A Shelef
Journal:  J Autoimmun       Date:  2017-02-07       Impact factor: 7.094

8.  PADI4 haplotypes in association with RA Mexican patients, a new prospect for antigen modulation.

Authors:  Maria Guadalupe Zavala-Cerna; Norma Guadalupe Gonzalez-Montoya; Arnulfo Nava; Jorge I Gamez-Nava; Maria Cristina Moran-Moguel; Roberto Carlos Rosales-Gomez; Susan Andrea Gutierrez-Rubio; Jose Sanchez-Corona; Laura Gonzalez-Lopez; Ingrid Patricia Davalos-Rodriguez; Mario Salazar-Paramo
Journal:  Clin Dev Immunol       Date:  2013-12-22

9.  PADI4 and the HLA-DRB1 shared epitope in juvenile idiopathic arthritis.

Authors:  Kaori Hisa; Masakatsu D Yanagimachi; Takuya Naruto; Takako Miyamae; Masako Kikuchi; Rhoki Hara; Tomoyuki Imagawa; Shumpei Yokota; Masaaki Mori
Journal:  PLoS One       Date:  2017-02-09       Impact factor: 3.240

10.  PADI4 genotype is not associated with rheumatoid arthritis in a large UK Caucasian population.

Authors:  Marian L Burr; Haris Naseem; Anne Hinks; Steve Eyre; Laura J Gibbons; John Bowes; Anthony G Wilson; James Maxwell; Ann W Morgan; Paul Emery; Sophia Steer; Lynne Hocking; David M Reid; Paul Wordsworth; Pille Harrison; Wendy Thomson; Jane Worthington; Anne Barton
Journal:  Ann Rheum Dis       Date:  2009-05-25       Impact factor: 19.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.